Account Based Marketing (ABM) segment for B2B targeting people who work at Idexx Laboratories in the Biotechnology industry. Feel free to add as many companies you like to the shopping cart and we will assist you in activating your campaign in the marketing platforms you choose. Idexx Laboratories has over 5722. AccountsGraph by Skydeo has 11,138 users available for digital targeting and 4,061 contacts with emails, titles, phone, address, LinkedIn URLs, etc. to update your CRM for account-based marketing.
You may reference segment ID – 500700917 or by name *AccountsGraph.com > Biotechnology > Idexx Laboratories.
About Idexx Laboratories: 7,000 people, one global focus – enhancing the health and well-being of pets, people, and livestockIDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, IDEXX conducts operations through more than 70 locations around the world and serves customers in over 175 countries.IDEXX’s primary business focuses on pet health, a growing market around the world. IDEXX products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX also develops and manufactures diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, careers.idexx.com, for further information and to view all of our job opportunities.. idexx.com
SIC CODE:
AccountsGraph taxonomy is available for Google, Facebook, TikTok, Snapchat, The Trade Desk, Verizon Media Yahoo, and many more via LiveRamp. Please contact us if you have any questions.